Answers are grounded in this paper and cite their sources.
Preeclampsia is a complex and multifaceted disease that occurs in approximately 2—5% of pregnant women and remains one of the main causes of maternal and perinatal morbidity and mortality worldwide. The manifestations of preeclampsia can range from mild, almost asymptomatic forms to severe conditions that can lead to eclampsia or HELLP syndrome. Despite significant progress in understanding the mechanisms of preeclampsia, it remains a challenging task for diagnosis and treatment. In recent years, scientists have been actively researching the pathophysiology of this disease and its various phenotypes, developing comprehensive diagnostic criteria, searching for new biomarkers, and creating effective prevention and monitoring strategies. However, despite all efforts, expert opinions and clinical guidelines on preeclampsia often differ. This review summarizes current world views and existing disagreements about various models of the pathophysiology of this condition. Special attention is paid to the phenotypes of preeclampsia in the context of existing models.
No takes yet. Share an insight, caveat, or question.
Lyashko et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: